Your browser doesn't support javascript.
loading
ASCEND-7: Efficacy and Safety of Ceritinib Treatment in Patients with ALK-Positive Non-Small Cell Lung Cancer Metastatic to the Brain and/or Leptomeninges.
Chow, Laura Q M; Barlesi, Fabrice; Bertino, Erin M; van den Bent, Martin J; Wakelee, Heather A; Wen, Patrick Y; Chiu, Chao-Hua; Orlov, Sergey; Chiari, Rita; Majem, Margarita; McKeage, Mark; Yu, Chong-Jen; Garrido, Pilar; Hurtado, Felipe K; Arratia, Pilar Cazorla; Song, Yuanbo; Branle, Fabrice; Shi, Michael; Kim, Dong-Wan.
Afiliação
  • Chow LQM; University of Washington, Seattle, Washington and University of Texas at Austin, Dell Medical School, Department of Oncology, Austin, Texas.
  • Barlesi F; Aix-Marseille University, CNRS, INSERM, CRCM, APHM, Marseille, France.
  • Bertino EM; The Ohio State University Comprehensive Cancer Centre, Arthur G James Cancer Hospital and Richard J Solove Research Institute, Columbus, Ohio.
  • van den Bent MJ; Department of Neurology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • Wakelee HA; Stanford University, Stanford, California.
  • Wen PY; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts.
  • Chiu CH; Department of Chest Medicine, Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan.
  • Orlov S; State Pavlov Medical University, St. Petersburg, Russia.
  • Chiari R; Department of Oncology, AULSS6 Euganea, Padova, Italy.
  • Majem M; Hospital de La Santa Creu I Sant Pau, Barcelona, Spain.
  • McKeage M; University of Auckland, Auckland, New Zealand.
  • Yu CJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Garrido P; Department of Medical Oncology, Hospital Universitario Ramon Y Cajal, Madrid, Spain.
  • Hurtado FK; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Arratia PC; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Song Y; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Branle F; Novartis Pharma AG, Basel, Switzerland.
  • Shi M; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Kim DW; Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Hospital, Seoul, Republic of Korea.
Clin Cancer Res ; 28(12): 2506-2516, 2022 06 13.
Article em En | MEDLINE | ID: mdl-35091443
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Segunda Neoplasia Primária / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Segunda Neoplasia Primária / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article